USA Chicago PMI for Oct 68.400 vs 63.500 consensus estimate. The prior reading was 64.700.
Apellis Pharma Highlights Results From Phase 3 DERBY, OAKS Studies Of Pegcetacoplan For Geographic Atrophy Presented At Association for Research in Vision and Ophthalmology May 1-4
Monthly and every-other-month treatment with pegcetacoplan showed a continuous and clinically meaningful reduction in the growth of both extrafoveal and foveal lesions at month 18 (all p-values
